During the past decade, Clinical Trials of SWLA, LLC conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 20 clinical trials were completed, i.e. on average, 60.6% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 20 clinical trials were completed. i.e. 181.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Trials of SWLA, LLC" #1 sponsor was "Celgene" with 5 trials, followed by "Shire" with 5 trials sponsored, "Allergan" with 3 trials sponsored, "Incyte Corporation" with 3 trials sponsored and "Arena Pharmaceuticals" with 3 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Trials of SWLA, LLC" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "Athenex, Inc." with 1 trials as a collaborator and "Premier Research Group plc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Trials of SWLA, LLC" are "Ulcerative Colitis" (8 trials), "Crohn Disease" (5 trials), "Crohn's Disease" (4 trials), "Colorectal Cancer" (3 trials) and "Diabetes Mellitus" (3 trials). Many other conditions were trialed in "Clinical Trials of SWLA, LLC" in a lesser frequency.

Most popular intervention types in "Clinical Trials of SWLA, LLC" are "Drug" (28 trials), "Other" (8 trials), "Biological" (2 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Ontamalimab" (4 trials), "Ozanimod" (3 trials), "Relamorelin" (3 trials) and "Etrasimod" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Trials of SWLA, LLC" are 33 trials for "All" genders.

Currently, there are NaN active trials in "Clinical Trials of SWLA, LLC". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Clinical Trials of SWLA, LLC, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Trials of SWLA, LLC, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".